Log in to save to my catalogue

Elevations in NLR at the first year of pirfenidone treatment may be associated with worse prognosis...

Elevations in NLR at the first year of pirfenidone treatment may be associated with worse prognosis...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f9d0f8c7a9aa4ee09224320ef83608a1

Elevations in NLR at the first year of pirfenidone treatment may be associated with worse prognosis in patients with idiopathic pulmonary fibrosis

About this item

Full title

Elevations in NLR at the first year of pirfenidone treatment may be associated with worse prognosis in patients with idiopathic pulmonary fibrosis

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

The Egyptian Journal of Bronchology, 2024-12, Vol.18 (1), p.28-7, Article 28

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Background
The purpose of this study was to evaluate the hemogram parameters, namely NLR and PLR, at the end of the first year of antifibrotic treatment in IPF patients and evaluate the association of change in NLR and PLR levels and mortality in this study population. Patients diagnosed with IPF and started on antifibrotic therapy between 2016...

Alternative Titles

Full title

Elevations in NLR at the first year of pirfenidone treatment may be associated with worse prognosis in patients with idiopathic pulmonary fibrosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_f9d0f8c7a9aa4ee09224320ef83608a1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f9d0f8c7a9aa4ee09224320ef83608a1

Other Identifiers

ISSN

2314-8551,1687-8426

E-ISSN

2314-8551

DOI

10.1186/s43168-024-00280-3

How to access this item